Cookie Einstellungen
Diese Webseite verwendet ausschließlich notwendige Cookies, die für die Funktion erforderlich sind. Marketing- und Statistik-Cookies kommen nicht zum Einsatz. Weitere Informationen finden Sie in unserer Datenschutzerklärung.
 Notwendig   Details einblenden
      OK      
Bitte logge Dich ein, um diese Funktion zu nutzen!
      OK      
x
Impact News +++ INVESTOR DEADLINE AUGUST 25: Sarepta Therapeutics, Inc. Investors with Substantial Losses Have Opportunity... (PR Newswire) +++ SAREPTA Aktie +5,13%

COLOPLAST Aktie

 >COLOPLAST Aktienkurs 
83.54 EUR    -1.0%    (Tradegate)
Ask: 83.6 EUR / 40 Stück
Bid: 83.58 EUR / 40 Stück
Tagesumsatz: 2014 Stück
Realtime Kurs von 8 bis 22 Uhr!
COLOPLAST Aktie über LYNX handeln
>COLOPLAST Performance
1 Woche: +3,8%
1 Monat: +4,3%
3 Monate: -2,7%
6 Monate: -21,6%
1 Jahr: -31,1%
laufendes Jahr: -21,3%
>COLOPLAST Aktie
Name:  COLOPLAST NAM. B DK 1
Land:  Dänemark
Sektor:  Gesundheit
ISIN/ Wkn:  DK0060448595 / A1KAGC
Symbol/ Ticker:  CBHD (Frankfurt)
Kürzel:  FRA:CBHD, ETR:CBHD, CBHD:GR
Index:  -
Webseite:  https://www.coloplast.com..
Profil:  Coloplast A/S operates as a major player in the he..
>Volltext..
Marktkapitalisierung:  18159.36 Mio. EUR
Unternehmenswert:  21298.42 Mio. EUR
Umsatz:  3767.4 Mio. EUR
EBITDA:  1213.62 Mio. EUR
Nettogewinn:  550.91 Mio. EUR
Gewinn je Aktie:  2.45 EUR
Schulden:  3273.68 Mio. EUR
Liquide Mittel:  98.15 Mio. EUR
Operativer Cashflow:  869.02 Mio. EUR
Bargeldquote:  0.07
Umsatzwachstum:  5.9%
Gewinnwachstum:  -17.99%
Dividende je Aktie:  2.94 EUR
Dividendenrendite:  3.64%
Dividendenschätzung:  3.64%
Div. Historie:  08.05.25 - 0.66955€
06.12.24 - 2.27511€
>weitere anzeigen...
Insiderhandel:  -
Suchwörter:  COLOPLAST
Letzte Datenerhebung:  21.08.25
>COLOPLAST Kennzahlen
Aktien/ Unternehmen:
Aktien: 207.37 Mio. St.
Frei handelbar: 68.52%
Leerverk. Aktien: -
Rückkaufquote: -0.21%
Mitarbeiter: 16639
Umsatz/Mitarb.: 0.21 Mio. EUR
Analysten:
Analystenrating: Neutral
Kursziel: 15.18%
Bewertung:
KGV: 34.15
KGV lG: 28.68
KUV: 4.78
KBV: 8.47
PEG-Ratio: -
EV/EBITDA: 17.55
Rentabilität:
Bruttomarge: 67.55%
Gewinnmarge: 14.62%
Operative Marge: 27.37%
Managementeffizenz:
Gesamtkaprendite: 8.45%
Eigenkaprendite: 24.72%
 >COLOPLAST Anleihen 
Es sind 2 Anleihen zur COLOPLAST Aktie bekannt.
>COLOPLAST Peer Group

Es sind 20 Aktien bekannt.
 
19.08.25 - 16:09
Coloplast A/S - Interim Financial Report, 9M 2024/25 (GlobeNewswire EN)
 
Coloplast A/S - Interim Financial Report, 9M 2024/25...
19.08.25 - 15:48
Coloplast A/S – Updated presenters list for Capital Markets Day on 2 September 2025 (GlobeNewswire EN)
 
Following the changes to the Executive Leadership Team, announced on 19.08.2025*, we are pleased to share with you the updated presenters list for our Capital Markets Day on 2 September 2025. For those of you who have signed up, we look forward to seeing you at the event. ...
19.08.25 - 08:54
Coloplast profit falls 26% on tax hit despite 7% organic sales growth (Investing.com)
 
Um den gesamten Artikel unter investing.com zu lesen, klicken Sie bitte auf die Überschrift...
19.08.25 - 08:48
Coloplast Q3 Profit Down, But Revenue Edges Up (AFX)
 
COPENHAGEN (dpa-AFX) - Coloplast A/S (COLOb.CO) Tuesday reported profit before tax of DKK 1.342 billion for the third quarter, 18% lower than DKK 1.631 billion in the same quarter a year ago, prim......
19.08.25 - 08:24
Coloplast A/S Non-GAAP EPS of DKK 3.86, revenue of DKK 6.96B; reaffirms FY outlook (SeekingAlpha)
 
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...
19.08.25 - 07:33
Coloplast A/S - Announcement no. 05/2025 - Coloplast announces changes to Executive Leadership Team (GlobeNewswire EN)
 
Coloplast announces changes to Executive Leadership Team...
08.08.25 - 09:39
Coloplast A/S - 9M 2024/25 Earnings Release - Invitation to conference call on 19 August 2025 at 11.00am CEST (GlobeNewswire EN)
 
Tuesday, 19 August 2025 at 11.00 - 12.00h CESTIn connection with the publication of Coloplast's interim financial results for 9M 2024/25, to be released same day in the morning around 07.30h CEST, Coloplast will host a conference call to present the financial results and answer questions from investors and financial analysts. A presentation will be available on Coloplast's website approximately 1 hour before the conference call.The webcast of the conference call will be available during and after the event....
07.07.25 - 14:36
Terry Smith Blasts Novo, Coloplast in Danish Life Science Rebuke (Bloomberg)
 
Terry Smith slammed two of Denmark's largest life sciences companies — Novo Nordisk A/S and Coloplast A/S — after they weighed on the equity fund run by the man often dubbed 'Britain's Warren Buffett.'...
03.06.25 - 13:00
Coloplast A/S - Invitation to Coloplast′s Capital Markets Day on 2 September 2025 (GlobeNewswire EN)
 
The event will take place on Tuesday, 2 September 2025 at Clarion Hotel (Copenhagen airport)Ellehammersvej 20, 2770 Kastrupfrom 10.30 - 17.00 CEST(Central European Summer Time)...
07.05.25 - 23:48
XETR: DIVIDEND/INTEREST INFORMATION - 08.05.2025 - DK0060448595 (XETRA)
 
Das Instrument CBHD DK0060448595 COLOPLAST NAM. B DK 1 EQUITY wird ex Dividende/Zinsen gehandelt am 08.05.2025 The instrument CBHD DK0060448595 COLOPLAST NAM. B DK 1 EQUITY has its ex-dividend/interest day on 08.05.2025...
06.05.25 - 12:31
Coloplast Seeks to Restore Investor Trust With Firing of CEO (Bloomberg)
 
Coloplast A/S fired its chief executive officer to restore investor confidence after the medical equipment maker failed to deliver sufficient shareholder returns....
06.05.25 - 11:36
Coloplast shares fall 5% after CEO exit, weaker Q2 results (Investing.com)
 
Um den gesamten Artikel unter investing.com zu lesen, klicken Sie bitte auf die Überschrift...
05.05.25 - 17:15
Coloplast A/S CEO Kristian Villumsen steps down as of today (GlobeNewswire EN)
 
Coloplast CEO Kristian Villumsen steps down from his CEO position as of today. The Board of Directors has asked Lars Rasmussen to step in as interim CEO....
01.05.25 - 12:27
Coloplast A/S Revised guidance for FY 2024/25 (GlobeNewswire EN)
 
Coloplast revises financial guidance for FY 2024/25 and pre-announces H1 2024/25 key financial figures...
15.04.25 - 14:09
Coloplast A/S - H1 2024/25 Earnings Release - Invitation to conference call on 6 May 2025 at 11.00am CEST (GlobeNewswire EN)
 
Tuesday, 6 May 2025 at 11.00 - 12.00am CESTIn connection with the publication of Coloplast's interim financial results for H1 2024/25, to be released same day around 07.30am CEST, Coloplast will host a conference call to present the financial results and answer questions from investors and financial analysts. A presentation will be available on Coloplast's website approximately 1 hour before the conference call.The webcast of the conference call will be available during and after the event....
27.03.25 - 14:00
Arjo appoints Eva Brike as new Executive Vice President Human Resources & Sustainability and member of the Arjo Management Team (Cision)
 
Arjo has appointed Eva Brike as new EVP Human Resources & Sustainability starting June 1, 2025. Eva succeeds Marion Gullstrand, who after a long operational career has chosen to pursue new opportunities. Eva Brike most recently held the position of Vice President People & Culture at Atos Medical, part of Coloplast. She has a solid background that also includes positions at Rosti Group and Resurs Bank. “We are very pleased to welcome Eva Brike to Arjo. Her experience and expertise will be an asset in the continued work to strengthen both the organization and our leadership and culture –...
>Behalte deine Investments mit realtime Kursen & News im Blick. Finde neue spannende Aktien! Registriere Dich und werde Mitglied!
Zitat des Tages: Das nackte Kind, das zagt nicht; mit seinem Pfennig springt es fort und kennt recht gut den Sammelort - ich meine des Bäckers Laden. - Johann Wolfgang von Goethe
Partner:    >Tradegate Börse | >Dukascopy | >Boersentreff- Partner

Börsentreff auf Facebook | Börsentreff auf X | Börsentreff auf Instagram

Copyright @ Boersentreff.de - Die Märkte im Blick!